Mercury Laboratories Ltd — Important, 31-05-2026: Company Update

Mercury Laboratories Limited has disclosed its audited financial results for the quarter and year ended March 31, 2026. For the quarter, total income from operations was 2.04 Cr, with a net profit after tax of 1.23 Cr. Annually, the company reported a total income of 75.94 Cr and a net profit after tax of 4.83 Cr. Equity share capital stands at 1.20 Cr, and reserves are 56.88 Cr. Earnings per share for the quarter were 10.21, rising to 40.28 for the full year. The Board approved these results on May 29. The company operates solely in the Pharmaceuticals Products segment.